Moderna announced Tuesday that it has requested emergency approval for its updated COVID-19 vaccine from the Food and Drug Administration.
Why it matters: Doses of the updated vaccine, which better target new coronavirus variants, will be ready to ship next month if the FDA grants clearance, according to a Moderna news release.
- Competitor Pfizer Inc. and BioNTech SE also announced Monday that they have applied for FDA approval for their new booster dose.
The big picture: Public health officials have been eyeing a long-term strategy for COVID vaccinations, addressing the risk of new variants and the need for new boosters, Axios' Adriel Bettelheim reports.
